Todd Stevens
Internal Medicine · Grand Rapids, MINPI 1396793394
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 422 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,616 and has fallen 91.6% since, to $221 in 2023. Among internal medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 422 payments — averaging $15.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$958
- Boehringer Ingelheim$771
- AstraZeneca$634
- Amarin Pharma, Inc.$436
- Pfizer$386
- AbbVie$372
- plus $3K from 33 others
What the payments were for
- Food & beverage$6,48098%
- Education$1062%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 57 | $958 |
| Boehringer Ingelheim | 49 | $771 |
| AstraZeneca(2 entities) | 37 | $634 |
| Amarin Pharma, Inc. | 35 | $436 |
| Pfizer | 26 | $386 |
| AbbVie | 25 | $372 |
| Lilly USA, LLC | 28 | $367 |
| Johnson & Johnson | 19 | $246 |
| Bayer | 14 | $204 |
| Novartis | 13 | $198 |
| Amgen | 10 | $184 |
| Merck | 9 | $171 |
| E.r. Squibb & Sons, L.L.C. | 11 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $169 |
| Sanofi-aventis U.S. LLC | 9 | $164 |
| GSK | 16 | $152 |
| Astellas Pharma US Inc | 8 | $146 |
| Biohaven Pharmaceuticals, Inc. | 5 | $117 |
| Daiichi Sankyo Inc. | 6 | $110 |
| Sanofi Pasteur Inc. | 4 | $79 |
| Grifols USA, LLC | 3 | $67 |
| Nestle Healthcare Nutrition Inc. | 4 | $66 |
| Amneal Pharmaceuticals LLC | 3 | $50 |
| Seqirus USA Inc | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Abbott | 2 | $32 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Mylan Specialty L.p. | 2 | $30 |
| Radius Health, Inc. | 2 | $26 |
| Gilead | 2 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Philips North America LLC | 1 | $23 |
| GRT US Holding, Inc. | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Bardy Diagnostics, Inc. | 1 | $16 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
| Nabriva Therapeutics, PLC | 1 | $12 |
How this compares
$6,586 in reported general payments places this provider in the 90th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Grand Rapids
- Robert SelfeGrand Rapids$238K
- Celia EganGrand Rapids$54K
- Jeremy GentileGrand Rapids$44K
- Terry SmithAnn Arbor$2.3M
- Michael ValituttoKalamazoo$1.8M
- Ulka VaishampayanAnn Arbor$996K
- Tina AbrahamPontiac$834K
- Steven KatzmanLivonia$715K
- Adam FormanSouthfield$453K
- Saroj NeupaneDetroit$373K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.